These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 1272073)

  • 21. Differences in 24-hour urine composition between apatite and brushite stone formers.
    Moreira DM; Friedlander JI; Hartman C; Elsamra SE; Smith AD; Okeke Z
    Urology; 2013 Oct; 82(4):768-72. PubMed ID: 23791217
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibitory activity of whole urine: a comparison of urines from stone formers and healthy subjects.
    Ryall RL; Hibberd CM; Mazzachi BC; Marshall VR
    Clin Chim Acta; 1986 Jan; 154(1):59-67. PubMed ID: 3943225
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Physicochemical basis for formation of renal stones of calcium phosphate origin: calculation of the degree of saturation of urine with respect to brushite.
    Pak CY
    J Clin Invest; 1969 Oct; 48(10):1914-22. PubMed ID: 5822595
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of gender and age on calcium oxalate crystal growth inhibition by urine from relatives of stone forming patients.
    Bergsland KJ; Kinder JM; Asplin JR; Coe BJ; Coe FL
    J Urol; 2002 Jun; 167(6):2372-6. PubMed ID: 11992040
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Idiopathic calcium nephrolithiasis. 2. Differences between hypercalciuric and normocalciuric persons with recurrent kidney stone formation and persons without such a history.
    Wilson DR; Pylypchuk G; Ehrig U
    Can Med Assoc J; 1979 Mar; 120(6):666-9. PubMed ID: 436048
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Age, Body Mass Index, and Gender Predict 24-Hour Urine Parameters in Recurrent Idiopathic Calcium Oxalate Stone Formers.
    Otto BJ; Bozorgmehri S; Kuo J; Canales M; Bird VG; Canales B
    J Endourol; 2017 Dec; 31(12):1335-1341. PubMed ID: 29084490
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biochemical and physicochemical presentations of patients with brushite stones.
    Pak CY; Poindexter JR; Peterson RD; Heller HJ
    J Urol; 2004 Mar; 171(3):1046-9. PubMed ID: 14767267
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New methods of assessing crystal growth and saturation of brushite in whole urine: effect of pH, calcium and citrate.
    Pak CY; Rodgers K; Poindexter JR; Sakhaee K
    J Urol; 2008 Oct; 180(4):1532-7. PubMed ID: 18710766
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of hyperoxaluria in idiopathic calcium oxalate kidney stone disease.
    Baggio B; Gambaro G; Favaro S; Borsatti A
    Nephron; 1983; 35(1):11-4. PubMed ID: 6888620
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Etiological role of estrogen status in renal stone formation.
    Heller HJ; Sakhaee K; Moe OW; Pak CY
    J Urol; 2002 Nov; 168(5):1923-7. PubMed ID: 12394677
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Calcium phosphate supersaturation regulates stone formation in genetic hypercalciuric stone-forming rats.
    Bushinsky DA; Parker WR; Asplin JR
    Kidney Int; 2000 Feb; 57(2):550-60. PubMed ID: 10652032
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of oxalate and calcium oxalate activity and formation product ratio in patients with renal stones before and during treatment.
    Peña JC; Monforte MF; Briceño A
    J Urol; 1987 Nov; 138(5):1137-40. PubMed ID: 3669156
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modulatory effect of the 23-kD calcium oxalate monohydrate binding protein on calcium oxalate stone formation during oxalate stress.
    Asokan D; Kalaiselvi P; Varalakshmi P
    Nephron Physiol; 2004; 97(1):p23-30. PubMed ID: 15153748
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Calcium oxalate crystalluria and urine saturation in recurrent renal stone-formers.
    Robertson WG; Peacock M; Nordin BE
    Clin Sci; 1971 May; 40(5):365-74. PubMed ID: 5556093
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of Potassium Citrate on Calcium Phosphate Stones in a Model of Hypercalciuria.
    Krieger NS; Asplin JR; Frick KK; Granja I; Culbertson CD; Ng A; Grynpas MD; Bushinsky DA
    J Am Soc Nephrol; 2015 Dec; 26(12):3001-8. PubMed ID: 25855777
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Idiopathic calcium nephrolithiasis. 1. Differences in urine crystalloids, urine saturation with brushite and urine inhibitors of calcification between persons with and persons without recurrent kidney stone formation.
    Pylypchuk G; Ehrig U; Wilson DR
    Can Med Assoc J; 1979 Mar; 120(6):658-65. PubMed ID: 436047
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Data on the degree of saturation of urine with respect to calcium hydrogen phosphate in hypercalciuric children and renal stone formers.
    Szabó A; Reusz GS; Tulassay T
    Child Nephrol Urol; 1988-1989; 9(3):130-4. PubMed ID: 3252961
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thiazides reduce brushite, but not calcium oxalate, supersaturation, and stone formation in genetic hypercalciuric stone-forming rats.
    Bushinsky DA; Asplin JR
    J Am Soc Nephrol; 2005 Feb; 16(2):417-24. PubMed ID: 15647340
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of citrate on the urinary excretion of calcium and oxalate: relevance to calcium oxalate nephrolithiasis.
    Cowley DM; McWhinney BC; Brown JM; Chalmers AH
    Clin Chem; 1989 Jan; 35(1):23-8. PubMed ID: 2910576
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of hydrochlorothiazide on urine saturation with brushite, in vitro collagen calcification by urine, and urinary inhibitors of collagen calcification.
    Pylypchuk G; Ehrig U; Wilson DR
    Can Med Assoc J; 1978 Apr; 118(7):792-6. PubMed ID: 638910
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.